NCT03981731 (COHEC) is a NA clinical trial of Cardiac coherence in Breast Cancer, sponsored by Institut du Cancer de Montpellier - Val d'Aurelle.

Who is sponsoring NCT03981731?

NCT03981731 is sponsored by Institut du Cancer de Montpellier - Val d'Aurelle.

What drugs are being tested in NCT03981731?

Interventions in NCT03981731: Cardiac coherence.

What condition does NCT03981731 study?

NCT03981731 studies Breast Cancer, Gynecologic Cancer.

Is NCT03981731 still recruiting?

NCT03981731 is currently completed. Last updated 5 February 2026.

Last reviewed 2026-02-05 · How we verify

NCT03981731: COHEC

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Management of Perioperative Anxiety by the Cardiac Coherence Technique Coupled With a Hypnosis Session

Completed NA Last updated 5 February 2026

What this trial tests

NA trial testing Cardiac coherence in Breast Cancer in 53 participants. Completed in 14 January 2022.

Timeline

14 February 2020

Primary endpoint
14 January 2022

14 January 2022

Quick facts

Lead sponsor	Institut du Cancer de Montpellier - Val d'Aurelle
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	supportive care
Enrollment	53
Start date	14 February 2020
Primary completion	14 January 2022
Estimated completion	14 January 2022
Sites	1 location across France

Drugs / interventions tested

Cardiac coherence

Conditions studied

Breast Cancer — all drugs for Breast Cancer →
Gynecologic Cancer — all drugs for Gynecologic Cancer →

Sponsor

Institut du Cancer de Montpellier - Val d'Aurelle — full company profile →

Who can join

18 and older, female only, with Breast Cancer or Gynecologic Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

the investigator proposes to use the cardiac coherence technique coupled with a hypnosis session to improve post-operative recovery.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Benefits of cardiac coherence combined with medical hypnosis on preoperative anxiety before cancer surgery: the COHEC II study trial protocol.
Amraoui J, Bordenave L, Leclerc G, Salvignol G, et al · · 2023 · cited 2× · PMID 38086587 · DOI 10.1136/bmjopen-2023-072215
Cardiac coherence and medical hypnosis: a feasibility study of a new combined approach for managing preoperative anxiety in patients with breast or gynaecological cancer.
Amraoui J, Leclerc G, Jarlier M, Diaz J, et al · · 2024 · PMID 39381542 · DOI 10.1016/j.bjao.2024.100309

Verify or expand the search:

Other recruiting trials for Breast Cancer

Currently open trials in the same condition.

NCT06148038 — CBD for Breast Cancer Primary Tumors · Phase 1 · recruiting
NCT07405801 — A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus R · Phase 2 · recruiting
NCT07285993 — Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET · Phase 2 · recruiting
NCT07510698 — Same-Day Awake Mastectomy With Immediate Breast Reconstruction for Patients With Breast Cancer · NA · recruiting
NCT06768931 — Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer · Phase 2 · recruiting

Other Institut du Cancer de Montpellier - Val d'Aurelle trials

Trials by the same sponsor.

NCT07523152 — Assessment of Sexual Quality of Life Following Local Treatment (Radiotherapy With or Without Surgery) in Patients With H · NA · not yet recruiting
NCT07198971 — Feasibility Study Incorporating Music Therapy to Optimise the Smoking Cessation Process Coordinated by a Tobacco Addicti · NA · recruiting
NCT07043543 — Evaluation of the Clinical Utility of Online Adaptive Radiotherapy in Bladder Cancer (BLADAPT-GETUG V11) · NA · not yet recruiting
NCT07441941 — Single-Fraction Pulmonary Ablative Radiotherapy Outcomes and Quality-of-life Workup · recruiting
NCT06382818 — Personalization of Breast Radiotherapy According to Loco-regional Recurrence Risk and Toxicity Probability · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03981731 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Institut du Cancer de Montpellier - Val d'Aurelle
Last refreshed: 5 February 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03981731.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing